Insight, analysis & opinion from Joe Paduda
I’ve been remiss in not keeping faithful readers up to date on developments at CorVel. I had a chance to listen to their latest earnings call, and here’s the report. All in all, things are looking up, a bit. Revenue … Continue reading CorVel’s financials
Read More...Depends on who you listen to. I finally got around to listening to the August quarterly conference call re earnings, and the picture is rosier-than-rosy. The TPA acquisitions are paying off handsomely, earnings are up, new technology is driving up … Continue reading What’s up with CorVel?
Read More...I checked the stock price yesterday; CorVel dropped a bit more, and is now below $26, but still enjoying a PE of 19+. That’s down from the 38 PE from last fall, but still a bit of a premium compared … Continue reading Back to CorVel
Read More...The comp managed care marketplace has been changing rapidly, and no company has been more affected than CorVel. It looks like the company has decided to switch rather than fight. Why?
Read More...I think I’m starting to figure this out. Workers comp managed care firm CorVel is once again on the acquisition trail. Schaffer Companies, a Baltimore TPA, was acquired by CorVel with the deal announced yesterday. This deal follows by several … Continue reading CorVel – it’s getting a little clearer
Read More...In what can best be described as a possible return of completely rational behavior, CorVel’s stock is entering the stratosphere. From above.
Read More...CorVel continues to intrigue. After my last post/prognostication about the potential for CorVel to be on Coventry’s acquisitions-we’re-thinking-about list, trading volume jumped by 40%. I’m not claiming a causal relationship, just a statistical one. Since then, the average volume has … Continue reading Who’s buying CorVel?
Read More...CorVel’s stock has hit the stratosphere, giving the company a market cap of over half a billion dollars, and a PE of 37. The stock’s price has more than tripled in the last year, and trading has been particularly heavy … Continue reading Is there a First Health in CorVel’s future
Read More...CorVel’s stock has enjoyed a resurgence of late, and is currently trading near it’s 52 week high. Yes, earnings have rebounded from a few tough quarters, although revenues remain essentially flat. What’s really driving the numbers?
Read More...Corvel Corporation announced that earnings were up substantially although revenues dropped by 10% in the last quarter of 2005. EPS were up 45% from a year earlier, despite a decrease in revenues from $70 million to $63 million. The announcement … Continue reading Corvel earnings up, revenues down
Read More...